Insider Tracker SEC Form 4 insider trades
← All clusters
OBIO

Orchestra BioMed Holdings, Inc.

Healthcare Surgical & Medical Instruments & Apparatus Market cap: $339.6M All insider activity → Quote and statistics → Sign in to watch OBIO Sign in to set a price alert

AI summary Directors make open-market purchases of Orchestra BioMed Holdings, Inc. stock

46
Insider Score Band below 60
Research score
41
AI adjustment
+5

Research score, not a recommendation.

Total bought$158.1K5 Form 4 purchases
Distinct insiders3open-market buyers
Lead insiderFain Eric SDirector
Cluster window2026-05-14 → 2026-06-01active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
37%
Seniority executive rank of buyers (CEO/CFO/Director)
60%
Commitment purchase size relative to company & holdings
55%
Context buying into stock weakness signals conviction
48%
Timing coordinated purchases within a tight window
89%
Routine-purchase discount × 1.00
Company-type / offering discount × 1.00
Net insider selling penalty − 0

Why are they buying?

AI · discretionary · catalyst none · documented

Insiders likely bought shares following recent periodic financial reporting and market pricing levels without an explicit stated corporate catalyst.

Multiple directors including Eric S. Fain, David P. Hochman, and Jason Aryeh purchased shares in open-market transactions between May 14 and June 1, 2026.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

5 Form 4 trades · 3 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Filing
2026-05-14 Fain Eric S history of Fain Eric S's purchases Director 20,000 $4.13 $82.6K SEC filing for Fain Eric S (opens in a new tab)
2026-05-15 → 2026-06-01 Hochman David P 11 purchases with a 63-day result · median -3.5% Director 10,000 $3.80 avg $38.0K
2026-05-15 Hochman David P 5,000 $3.77 $18.9K SEC filing for Hochman David P (opens in a new tab)
2026-06-01 Hochman David P 5,000 $3.83 $19.1K SEC filing for Hochman David P (opens in a new tab)
2026-05-15 → 2026-05-18 Aryeh Jason 3 purchases with a 63-day result · median +29.0% Director 9,636 $3.89 avg $37.5K
2026-05-15 Aryeh Jason 8,971 $3.90 $35.0K SEC filing for Aryeh Jason (opens in a new tab)
2026-05-18 Aryeh Jason 665 $3.75 $2.5K SEC filing for Aryeh Jason (opens in a new tab)
Total $158.1K

Other buying runs at OBIO

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days -8.0%63 days +29.0%126 days –

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days63 days126 days Status
2025-08-01 → 2025-09-19 6 $2.0M 56 -11.7%+78.6%+47.8% closed
2020-08-04 → 2020-08-06 3 $4.8M 51 -6.3%-12.8%-7.4% closed